Skip to main content

Harmful Drugs Law

Search for an Attorney  

What actions were taken by the FDA after Ketek was linked to severe liver complications?

The FDA approved a labeling supplement submitted by Aventis Pharmaceuticals as a “Changes Being Effected” (CBE) supplement, which highlights the 'Warnings' section of the labeling to raise attention to the risk of liver toxicity associated with Ketek.

Was this helpful?